Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Clinical trial NCT05921253 · RECRUITING
Trial details
- NCT number
- NCT05921253
- Sponsor
- University of Oklahoma
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-09-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.